New Delhi A suo motu study on drug pricing by the Ministry of Corporate Affairs has revealed exorbitant profit margins on 21 common drugs manufactured by Indian companies.
Links:
[1] http://admin.indiaenvironmentportal.org.in/news/500-profit-margins-drugs-study
[2] http://admin.indiaenvironmentportal.org.in/category/author/abantika-ghosh
[3] http://admin.indiaenvironmentportal.org.in/category/newspaper/financial-express-new-delhi
[4] http://admin.indiaenvironmentportal.org.in/category/thesaurus/india
[5] http://admin.indiaenvironmentportal.org.in/category/thesaurus/drugs
[6] http://admin.indiaenvironmentportal.org.in/category/thesaurus/ministry-chemicals-and-fertilizers
[7] http://admin.indiaenvironmentportal.org.in/category/thesaurus/ministry-health-and-family-welfare
[8] http://admin.indiaenvironmentportal.org.in/category/thesaurus/ranbaxy-pharmaceuticals
[9] http://admin.indiaenvironmentportal.org.in/category/thesaurus/health-care
[10] http://admin.indiaenvironmentportal.org.in/category/thesaurus/planning-commission
[11] http://admin.indiaenvironmentportal.org.in/category/thesaurus/drug-industry
[12] http://admin.indiaenvironmentportal.org.in/category/thesaurus/industry